Histone deacetylase (HDAC)

Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Histone deacetylase (HDAC)

2 - Neurology 4 - Cancer 1 - Cancer 3 - Cancer 2 - Neurology 1 - Hematology 14 - Cancer 2 - Autoimmune 1 - Transplant 1 - Neurology 1 - Musculoskeletal 1 - Infectious 1 - Endocrine / Metabolic 7 - Cancer 1 - Neurology 1 - Hematology 13 - Cancer 1 - Cancer 2 - Endocrine / Metabolic 1 - Diagnostic 9 - Cancer
Phase of DevelopmentPreclinicalINDPhase IPhase I/IIPhase IIPhase IIIApprovedMarketed
Autoimmune

-

-

-

-

2

-

-

-

Cancer

9

1

13

7

14

3

1

4

Diagnostic

1

-

-

-

-

-

-

-

Endocrine / Metabolic

2

-

-

1

-

-

-

-

Hematology

-

-

1

-

1

-

-

-

Infectious

-

-

-

1

-

-

-

-

Musculoskeletal

-

-

-

1

-

-

-

-

Neurology

-

-

1

1

2

-

-

2

Transplant

-

-

-

1

-

-

-

-


 Products Targeting Histone deacetylase (HDAC)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

40

$24,149.0M

$499.1M

$3,065.1M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today